SCHEMBL9559685

SCHEMBL9559685

Oc1ccccc1C1=C2C=CC(=N2)C(c2ccccc2O)=C2C=CC(=N2)C(c2ccccc2O)=C2CCC(=N2)C(c2ccccc2O)=C2C=CC1=N2

nearest known ligand 0.30

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.30
▸ HSP90AA1 P07900 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL498541 0.83 ALDH1A1 (0.40) —
SCHEMBL9404581 0.76 HPGD (0.47) MEN1KMT2A
SCHEMBL8676971 0.72 — —
SCHEMBL9559703 0.71 ESR1 (0.31) —
SCHEMBL5104039 0.71 CHRNB4 (0.38) —
SCHEMBL5706544 0.71 HPGD (0.39) MEN1KMT2A
SCHEMBL5100896 0.70 CHRNB4 (0.38) —
SCHEMBL9718917 0.63 CYP2A6 (0.40) HSP90AA1KMT2A
SCHEMBL3118129 0.63 ALDH1A1 (0.46) MEN1KMT2A
SCHEMBL5918765 0.63 IDO1 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0337601-B1 PORPHYRINS AND MEDICAMENTS FOR CANCER TREATMENT SCOTIA HOLDINGS PLC (GB) 1993-05-05 — — EP claimed
EP-0337601-B1 PORPHYRINS AND MEDICAMENTS FOR CANCER TREATMENT SCOTIA HOLDINGS PLC (GB) 1993-05-05 — — EP disclosed
US-5162519-A Porphyrins and cancer treatment EFAMOL HOLDINGS PLC (GB) 1992-11-10 — — US disclosed
US-4992257-A Dihydroporphyrins and method of treating tumors EFAMOL HOLDINGS PLC (GB) 1991-02-12 — — US disclosed
Send feedback